Medigus Stock News

REHOVOT, Israel, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced the appointment of Ori Hershkovitz, a long-time life sciences industry investor, to its Board of Directors. "We are thrilled to welcome Ori to the Purple Biotech Board of Directors," said Dr. Eric Rowinsky, Chairman of the Board of Purple Biotech. "Ori has spent many years investing in and advising development-stage life sciences companies. We look forward to leveraging his industry and financial expertise as we continue to execute on our corporate growth initiatives." "Purple Biotech has a compelling oncology-focused pipeline, highlighted by CM24 and NT219, with a great potential to transform the therapeutic options of many cancer patients," said Mr. Hershkovitz. "I look forward to working with the other members of the Board and the Company''s experienced management team to support Purple Biotech''s continued development and to drive long-term shareholder value." Mr.

In recent pre-clinical studies, Polyrizon products demonstrated a great potential in preventing human coronavirus 229E and Influenza Virus H1N1 from interacting with epithelial host cells and by inhib

Tel Aviv, Israel, Dec. 01, 2021 (GLOBE NEWSWIRE) --  Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle a

Tel Aviv, Israel, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and

Which penny stocks are you watching next week? The post 3 Penny Stocks to Watch in the First Week of November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Cortex's revenues for H1 2021 amounted to approximately $13.5 million, an increase of 53% compared to H1 2020 Cortex's revenues for H1 2021 amounted to approximately $13.5 million, an increase of 53%

Medigus to invest $400,000 in Safee, an NFT-based ownership social network aiming to bring its unique technology to mass market creators and audiences

Tel Aviv, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and c

Revoltz Model One is a micro-mobility vehicle for last mile and food delivery. Revoltz Model One is a micro-mobility vehicle for last mile and food delivery.

In recent pre- clinical studies, Polyrizon products showed strong potential in preventing human coronavirus 229E and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting

In recent pre- clinical studies, Polyrizon products showed strong potential by preventing coronavirus and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells' deat

Gix Internet finished the first six months of 2021 with revenues of ~$ 16.4 million, Cortex Group Revenues for the first six months of 2021 amounted to ~$ 12.3 million Gix Internet finished the first

Privately held company Polyrizon Ltd, in which Medigus Ltd (NASDAQ: MDGS) owns 35.86% of share capital, has announced preclinical data for its Capture and Contain (C&C) platform technology. Rela

Polyrizon's formulations previously demonstrated high efficacy by preventing coronavirus from interacting with epithelial host cells Polyrizon's formulations previously demonstrated high efficacy by p